Metraipolis › archive › dc_218e43187b60

Molecular profile of residual triple-negative breast cancer: opportunities for post-neoadjuvant therapeutic interventions — Europe PMC PMID:42120393

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42120393
DOI
10.1038/s41523-[numero omesso]-7
License (as archived)
solo-consultazione
Archived
2026-10-08T04:30:51.901Z
SHA-256 of the archived text
b79f2c2c3363719f48b7dacd053b3826c013ef19e721d329683c12abe1d0561f
Stable URL of this page
https://metraipolis.com/documento/dc_218e43187b60

How to cite

Molecular profile of residual triple-negative breast cancer: opportunities for post-neoadjuvant therapeutic interventions — Europe PMC PMID:42120393 — Europe PMC (en), https://europepmc.org/article/MED/42120393 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_218e43187b60 (Metraipolis archive dc_218e43187b60, sha256 b79f2c2c3363719f48b7dacd053b3826c013ef19e721d329683c12abe1d0561f)
BibTeX
@misc{dc218e43187b60,
  title = {Molecular profile of residual triple-negative breast cancer: opportunities for post-neoadjuvant therapeutic interventions — Europe PMC PMID:42120393},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42120393},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_218e43187b60; sha256 b79f2c2c3363719f48b7dacd053b3826c013ef19e721d329683c12abe1d0561f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42120393. Agents can read the archived copy with the MCP tool read_document.